Fibroblast Growth Factor 23: Mineral Metabolism and beyond

Alexander Grabner, Sandro Mazzaferro, Giuseppe Cianciolo, Stefanie Krick, Irene Capelli, Silverio Rotondi, Claudio Ronco, Gaetano La Manna, Christian H Faul

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Patients affected by chronic kidney disease (CKD) exhibit a high risk of cardiovascular mortality that is poorly explained by traditional risk factors. There is a growing awareness about the role of derangement of mineral metabolism that is currently accepted as a trigger and sustainer of cardiovascular disease (CVD) in CKD patients. The synthetic definition of CKD mineral and bone disorder (CKD-MBD) split the concept that the indexes of mineral metabolism extend their effects beyond the bone until the vascular wall and metabolic milieu of CKD patients through complex pathways. A better understanding of the biomarkers and mechanisms of left ventricular hypertrophy, CVD, inflammation, and chronic renal damage may help with the diagnosis and treatment of the systemic impairment that occurs secondary to CKD-MBD, thus slowing the progression of renal and CVD and improving patient survival. Recent insights into fibroblast growth factor (FGF) 23 have led to marked advancement in interpreting data on CVD and CKD progression ascribing to FGF23 a pivotal role in these pathologies independent of its co-receptor klotho and well beyond mineral metabolism. This review article will discuss the current experimental and clinical evidence regarding the role of FGF23 in physiology and pathophysiology of CKD and its associated complications with an emphasis on CVD.

Original languageEnglish (US)
Pages (from-to)83-95
Number of pages13
JournalContributions to Nephrology
Volume190
DOIs
StatePublished - 2017

ASJC Scopus subject areas

  • Medicine(all)
  • Nephrology

Fingerprint Dive into the research topics of 'Fibroblast Growth Factor 23: Mineral Metabolism and beyond'. Together they form a unique fingerprint.

  • Cite this

    Grabner, A., Mazzaferro, S., Cianciolo, G., Krick, S., Capelli, I., Rotondi, S., Ronco, C., La Manna, G., & Faul, C. H. (2017). Fibroblast Growth Factor 23: Mineral Metabolism and beyond. Contributions to Nephrology, 190, 83-95. https://doi.org/10.1159/000468952